Conversely, emerging evidence indicates the protective role of IL-22 against NAFLD by improving antioxidant status and liver injury, primarily mediated by promoting STAT3 phosphorylation [40]. The gene discussed is IL22; the disease is metabolic dysfunction-associated steatotic liver disease.